Reuters logo
BRIEF-Ritter Pharmaceuticals Q3 loss per share $0.41
November 7, 2016 / 2:18 PM / a year ago

BRIEF-Ritter Pharmaceuticals Q3 loss per share $0.41

Nov 7 (Reuters) - Ritter Pharmaceuticals Inc

* Ritter pharmaceuticals-topline results of phase 2b/3 clinical trial of rp-g28 for treatment of lactose intolerance expected to be announced in q1 2017

* Ritter pharmaceuticals reports third quarter 2016 financial results and provides business update

* Q3 loss per share $0.41

* Q3 earnings per share view $-0.50 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below